Related Experiment Videos
Mortality-lowering effect of systemic corticosteroid therapy in severe tetanus
S Paydaş1, T F Akoğlu, H Akkiz
1Department of Internal Medicine, Marmara University Medical School, Istanbul, Turkey.
Clinical Therapeutics
|January 1, 1988
Summary
Adding corticosteroids like prednisolone to standard tetanus treatment significantly reduces mortality. This finding highlights the potential of corticosteroid therapy in managing severe tetanus cases, complementing essential nursing care.
Area of Science:
- Infectious Diseases
- Clinical Medicine
- Pharmacology
Background:
- Tetanus is a severe bacterial infection with high mortality rates.
- Standard treatment for tetanus includes supportive care and antitoxins.
- The role of corticosteroids in tetanus management has been investigated.
Purpose of the Study:
- To evaluate the efficacy of prednisolone as an adjunct to standard treatment for severe tetanus.
- To compare mortality rates between patients receiving prednisolone and those receiving a placebo.
Main Methods:
- A double-blind therapeutic trial was conducted.
- 32 patients with severe tetanus received prednisolone plus standard treatment.
- 31 patients received a placebo plus standard treatment.
Main Results:
- Mortality was significantly lower in the prednisolone group (31%) compared to the placebo group (55%).
- Women experienced more severe symptoms and higher mortality rates than men.
- Prednisolone administration was associated with reduced mortality.
Conclusions:
- Corticosteroid addition to standard tetanus treatment can lower mortality.
- Meticulous nursing care remains the most critical factor in tetanus management.
- Further research may explore optimal corticosteroid regimens for tetanus.